Carbapenemase-producing Pseudomonas aeruginosa isolated from patients exhibited multidrug resistance in Sokoto, Nigeria

Carbapenemase-producing P. aeruginosa is one of the top priority pathogens responsible for treatment failures in cystic fibrosis, abscess and soft tissue infections. The study aimed to determine the prevalence of carbapenemase-producing P. aeruginosa in patients visiting two major public hospitals in Sokoto, Nigeria. Two hundred and four samples were collected from in- and outpatients attending two major public hospitals in Sokoto, Nigeria. Identifying P. aeruginosa involved culturing on cetrimide agar and confirming by PCR detection of the oprI and oprL genes specific to P. aeruginosa. Isolates were screened for sensitivity to ten antibiotics using the Kirby-Bauer disc diffusion test. To identify carbapenemase production, isolates resistant to meropenem and imipenem were further screened using the combined disc synergy test. Molecular detection of carbapenemase was done using PCR detection of bla VIM , bla KPC and bla IMP genes. Out of the 204 samples collected, 26 (12.7%) of P. aeruginosa were recovered. All 26 isolates demonstrated resistance to more than three classes of antibiotics tested. Notably, 19.2 % (5/26) of the isolates were pan-drug-resistant to all antibiotics tested. Besides, 65.4 % (14/26) of isolates were at least resistant to ampicillin, kanamycin, cefotaxime, trimethoprim and chloramphenicol. A combined disk synergy test showed six isolates to produce carbapenemase enzyme. Likewise, bla VIM and bla IMP were detected in all of these isolates, while bla KPC was not detected in any. The presence of carbapenemase-producing P. aeruginosa (carrying bla VIM and bla IMP genes) among hospital patients in Sokoto and the high antibiotic resistance detected represent a challenging threat to public health. Further research is crucial to understanding this carbapenemase gene's transmission source and developing effective strategies to combat it. • We investigated two major hospitals in Sokoto, Nigeria, to determine the prevalence of Carbapenemase-producing Pseudomonas aeruginosa infection. • This study reported a moderate prevalence of P. aeruginosa resistant to at least three different classes of antibiotics. • We detected the bla VIM and bla IMP resistant genes.

Authors

Institutions

Publication Details

Journal
Medicine in Microecology
Published
2025-06-07
DOI
https://doi.org/10.1016/j.medmic.2025.100134
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Carbapenemase-producing Pseudomonas aeruginosa isolated from patients exhibited multidrug resistance in Sokoto, Nigeria

Muhammad Bashir Bello, Abdulmalik Bello Shuaibu, Adamu Nuhu, Abdurrahman Hassan Jibril et al.
1 links
Medicine in Microecology
Antibiotic Resistance in Bacteria
article

Carbapenemase-producing Pseudomonas aeruginosa isolated from patients exhibited multidrug resistance in Sokoto, Nigeria

Muhammad Bashir Bello, Abdulmalik Bello Shuaibu, Adamu Nuhu, Abdurrahman Hassan Jibril, Kabiru Mohammed, Hassan Bawa, Farhan Rhidor Akorede, Olalekan Adesola
article en

Abstract

Carbapenemase-producing P. aeruginosa is one of the top priority pathogens responsible for treatment failures in cystic fibrosis, abscess and soft tissue infections. The study aimed to determine the prevalence of carbapenemase-producing P. aeruginosa in patients visiting two major public hospitals in Sokoto, Nigeria. Two hundred and four samples were collected from in- and outpatients attending two major public hospitals in Sokoto, Nigeria. Identifying P. aeruginosa involved culturing on cetrimide agar and confirming by PCR detection of the oprI and oprL genes specific to P. aeruginosa. Isolates were screened for sensitivity to ten antibiotics using the Kirby-Bauer disc diffusion test. To identify carbapenemase production, isolates resistant to meropenem and imipenem were further screened using the combined disc synergy test. Molecular detection of carbapenemase was done using PCR detection of bla VIM , bla KPC and bla IMP genes. Out of the 204 samples collected, 26 (12.7%) of P. aeruginosa were recovered. All 26 isolates demonstrated resistance to more than three classes of antibiotics tested. Notably, 19.2 % (5/26) of the isolates were pan-drug-resistant to all antibiotics tested. Besides, 65.4 % (14/26) of isolates were at least resistant to ampicillin, kanamycin, cefotaxime, trimethoprim and chloramphenicol. A combined disk synergy test showed six isolates to produce carbapenemase enzyme. Likewise, bla VIM and bla IMP were detected in all of these isolates, while bla KPC was not detected in any. The presence of carbapenemase-producing P. aeruginosa (carrying bla VIM and bla IMP genes) among hospital patients in Sokoto and the high antibiotic resistance detected represent a challenging threat to public health. Further research is crucial to understanding this carbapenemase gene's transmission source and developing effective strategies to combat it. • We investigated two major hospitals in Sokoto, Nigeria, to determine the prevalence of Carbapenemase-producing Pseudomonas aeruginosa infection. • This study reported a moderate prevalence of P. aeruginosa resistant to at least three different classes of antibiotics. • We detected the bla VIM and bla IMP resistant genes.

Medicine in MicroecologyVol. 25
University of Lagos (NG), Medical Laboratory Science Council of Nigeria (NG), Usmanu Danfodiyo University (NG)
Openalex Percentile: Top 90%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.